title: A rapid infusion protocol is safe for total dose iron polymaltose: time for change.
authors.affiliation: Department of Gastroenterology and Hepatology, Eastern Health, Melbourne, Victoria, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Garg
authors.forename: G
authors.initials: G
authors.lastname: Morrison
authors.forename: A
authors.initials: A
authors.lastname: Friedman
authors.forename: A
authors.initials: A
authors.lastname: Lau
authors.forename: D
authors.initials: D
authors.lastname: Lau
authors.forename: P R
authors.initials: PR
authors.lastname: Gibson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000188:drug therapy*; D002985:Clinical Protocols / Q000592:standards*; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced / Q000517:prevention & control; D007262:Infusions, Intravenous / Q000639:trends; D008297:Male; D008875:Middle Aged; D011134:Polysaccharides / Q000008:administration & dosage* / Q000009:adverse effects; D011446:Prospective Studies; D013997:Time Factors; D055815:Young Adult
chemical_list: D005290:Ferric Compounds; D011134:Polysaccharides; C013276:teferrol